DAY 1: 01 September

0800: Registration

0850: Welcome

Session 1: Phage therapy-1 – Chair Dr Mikeljon Nikolich

0900: Krystyna Dabrowska
Wrocław University of Science and Technology and Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland
Specific immune responses to phage therapy: the gut context

0920: Kiran Bosco
Westmead Institute for Medical Research, Sydney, New South Wales, Australia
Mammalian immune responses to phage therapy: Insights from clinical and experimental studies

0940: Carola Venturini
The University of Sydney, Sydney, New South Wales, Australia
Development of phage-based interventions against UPEC for companion animals with recurrent UTI

1000: Martha Clokie
University of Leicester, Leicester, UK
UTI phages; ecological insights, antibiotic synergies, and bladder models

1020: Refreshment break, poster viewing and networking

1050: Adrian Thaqi
German Research Center for Environmental Health, Neuherberg, Germany
Prophages Reshape Metabolism, Stress Tolerance, Biofilm Formation and Phage Resistance in Enterotoxigenic Escherichia coli

1110: Sónia Campos
Helmholtz Munich, Neuherberg, Germany
The Relevance of Phage-Encoded Proteins Against Chronic Acinetobacter baumannii Biofilm Infections in Mucosal Environments

1130: Tingjie Guo
Leiden University, Leiden, Netherland
Reframing PK/PD for rational treatment strategies in phage therapy

1150: Hubert Kasprzak
Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland 
Studies on the effects of bacteriophages on cytokine production by human peripheral blood immune cells  

1210: Marie-Agnès Petit
Université Paris-Saclay/INRAE, Jouy en Josas, France
Complementary killing activities of Pbunavirus LS1 and Bruynoghevirus LUZ24 phages on planktonic and sessile Pseudomonas aeruginosa PAO1 derivatives

1230: Panos Kalatzis
University of Copenhagen, Copenhagen, Denmark
Phage-based approaches to combat Streptococcus pyogenes in soft tissue necrotizing infections

1250: Lunch and networking

Session 2: Methods and technologies – Professor Rob Lavigne

1350: Stefan Vermeulen
University College Ghent, Ghent, Belgium
Development of a microfluidic platform for accurate and universal quantification of phages

1410: Hannah Rose Bonham
University of Ljubljana, Ljubljana, Slovenia
Capturing Infection in Action: Developing a Fluorescence Imaging Pipeline to Study Bacteriophage Infection and Lysis

1430: Florian Christoph Sigloch
PolyQuant GmbH, Bad Abbach, Germany
Universal host contaminant protein identification and quantification for any production host by LC-MS/MS

1450: Nina Vesel
University of Ljubljana, Ljubljana, Slovenia
Deciphering bacterial host control by phage regulatory switches at single cell level

1510: Amaya Albalat
University of Stirling, Stirling, UK
Phage-based shelf-life extension for valuable seafood products

1530: Refreshment break, poster viewing and networking

Session 3: ECR forum – short presentations – Chair Professor Amaya Albalat

1600: Aparna Mohan
University of Cambridge, Cambridge, UK
Single-cell analysis of the effects of cellular dormancy on the efficacy of bacteriophages

1610: Shahzeb Javed
University of Salerno, Fisciano, Italy
Stabilizing Bacteriophages in Alginate Hydrogels for 3D Printing Applications: a Customizable Platform for Targeted Antibacterial Therapy

1620: Ruizhe Li
University of Cambridge, Cambridge, UK
Host cell cycle and ribosomal resources drive T7 phage infection outcomes

1630: Marta Barbosa
University of Minho, Braga, Portugal
Targeting Pseudomonas aeruginosa on Multiple Fronts: Phage-Derived Proteins for Detection and Therapy

1640: Arezoo Pedramfar
University of Leicester, Leicester, UK
The development of targeted phage metagenomics

1650: Andrew Kinsella
University of Leicester, Leicester UK
Investigating the prevalence and diversity of prophages in Enterococcus genomes, and their role in AMR and virulence spread

1700: Anastasiya Gæde
University of Copenhagen, Copenhagen, Denmark
Phager: rapid identification of phage genomes and contigs using similarity-free, biological features-based machine learning

1710: Jan Torres-Boncompte
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana (CECAV), Castelló, Spain
Prophylactic in ovo administration of phages to enhance protection against Salmonella Typhimurium in broiler chickens

1720: Manuela Reuter
Max Planck Institute for Evolutionary Biology, Plön, Germany
Experimental evolution strategies to modulate bacteriophage life-history traits

1730: End of Day 1

1900: Networking dinner (further information will be sent by email)

DAY 2: 02 September

0900: Accommodation checkout

0925: Welcome

Session 4: Phage therapy-2 – Chair Professor Martha Clokie

0930: Rob Lavigne
University of Leuven, Leuven, Belgium
TBA

0950: Mikeljon Nikolich
Walter Reed Army Institute of Research, Silver Spring, MD, USA
Durable Fixed Cocktails Incorporating Globally Harvested Bacteriophages as Novel Antimicrobials for Multidrug-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae Infections

1010: Belinda Loh
Fraunhofer Institute for Cell Therapy & Immunology (IZI), Leipzig, Germany
Strategic Receptor Profiling Optimizes Phage Therapy for K1 Klebsiella pneumoniae

1030: Refreshment break, poster viewing and networking

Session 5: Phage-host interactions – Chair Dr Ben Temperton

1050: Gabriel Abreu
University of Minho, Braga, Portugal
From Genotype to Phenotype: Linking Erwinia amylovora Diversity to Bacteriophage Host Range

1110: Mojgan Rabiey
University of Warwick, Coventry, UK
Impact of phage therapy on Pseudomonas syringae pv. syringae and plant microbiome dynamics through coevolution and field experiments

1130: Ellie Tong
University of Exeter, Exeter, UK
Lipopolysaccharide truncation and restoration drives a trade-off in resistance to two phages in Pseudomonas aeruginosa

1150: Bing Liu
Xi’an Jiaotong University, Shaanxi, China
GIMM: A Novel Bacterial Defense Module Monitoring Genome Integrity and its Phage Countermeasure

1210: Sebastian Leptihn
Health and Medical University, Erfurt, Germany
A Genetic “Bulls-Eye”: Dissecting Fitness in Evolving Phage Populations

1230: Gábor Apjok
Biological Research Centre, Szeged, Hungary
Dissecting the Human Gut Phageome Reveals Genetic Drivers of Epithelial Interactions and Intracellular Trafficking

1250: Lunch, poster viewing and networking

Session 6: Molecular biology and bioinformatics – Dr Evelien Adriaenssens

1340: Thomas Sicheritz-Pontén
University of Copenhagen, Copenhagen, Denmark
Hidden in plain sight: Bacterial genomes reveal thousands of lytic phages with therapeutic potential

1400: Ryan Cochrane
University of Manchester, Manchester, UK
Smart-Phage: Towards Bottom-up Genome Engineering Technologies for PB1-like Bacteriophage

1420: François Lecointe
Université Paris-Saclay, INRAE, Jouy en Josas, France
Duplication-rich Felixounavirus genomes encode GlaF, a Gp2.5-like annealase defining a new family of phage recombinases

1440: Julien Lopez
Université Paris-Saclay, INRAE, Jouy en Josas, France
Genomic and genetic approaches for estimation of bacteriophage lambda’s mutation rate

1500: Nawshin Binte Alim
University of British Columbia, Vancouver, Canada
The Phage-like Gene Transfer Agent and its Receptors

1520: Closing remarks by Professor Clokie, general discussion, networking and departure